BGMD / BG Medicine, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

BG Medicine, Inc.
US ˙ OTCPK

Ausstehende Aktien 11,374,360 shares
Insider-Aktien3.139.776 shares
Insider-Besitz27,60 %
Insider gesamt25
Insider-Stimmungswert

Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.

Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Top-Optionen der Insider an, die eine Liste der Unternehmen mit der höchsten Insiderakkumulation enthalten.

Führungskräfte-Stimmungswert

Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.

Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.

Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Insiders Top-Auswahl an, die eine Liste der Unternehmen mit der höchsten Insider-Stimmung enthalten.

Wichtige Insider-Kennzahlen

Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.

Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).

Nettoanzahl der Insider, die kaufen (Rang)

0 ( )
2313 out of 10916

Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).

Prozent des Streubesitzes von Insidern gekauft (Rang)

0.000% ( )
2348 out of 10752

Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.

Diagramm zum Insiderhandel

BG Medicine, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.

Kennzahlen zu Insiderlisten und Rentabilität

Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.

See our leaderboard of most profitable insider traders.

Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst
Noubar Afeyan Director, 10% Owner - [D] [10%] 0 0
Charles H Jr Abdalian 140.000
Adourian Aram S. SVP & Chief Scientific Officer - [O] 40.036 40.036
Harrison M Jr Bains 4.205
Stephane Bancel Executive Chairman, Director - [D] [O] 123.167 30.792
Eric Bouvier President, CEO, Director - [D] [O] 10.000 2.500
William Densel 0
Flagship Ventures 2007 General Partner LLC 10% Owner - [10%] 882.142 882.142
Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst
Flagship Ventures Fund 2007, L.P. 10% Owner - [10%] 882.142 882.142
Neal Gordon 30.000
Gilde Europe Food & Agribusiness Partners II C.V. 10% Owner - [10%] 1.635.432 408.858
Stephen P Hall EVP & Chief Financial Officer - [O] 31.034 31.034
Harris Timothy J.R. 4.205
Jeffrey R Luber 0
Miller Stephen R. 30.000
Pieter Muntendam EVP, Chief Medical Officer - [O] 78.483 19.621
Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst
James F O Oconnor 0
Stelios Papadopoulos Director - [D] 1.187.713 296.928
Brian S Posner Director - [D] 20.000 5.000
Michael W Rogers 35.000
Anastasia Rader 42.000
Paul R Sohmer President & CEO, Director - [D] [O] 53.161 53.161
Haygood Paterson Sr Seawell - 1.308.965 1.308.965
Harry W Wilcox 5.000
der Meer Pieter van 10% Owner - [10%] 1.635.432 408.858

Report errors via our new Insider Auditing Tool

Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse

In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in BGMD / BG Medicine, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Max
Preis bei
Max
Max
Gewinn ($)
Max Rendite (%)
2013-01-30 PAPADOPOULOS STELIOS 250.000 2,0000 62.500 8,0000 500.000 12 8.8 50.000 10,00
2013-01-30 AFEYAN NOUBAR 1.050.000 2,0000 262.500 8,0000 2.100.000
2013-01-30 AFEYAN NOUBAR 500.000 2,0000 125.000 8,0000 1.000.000
2013-01-30 AFEYAN NOUBAR 75.000 2,0000 18.750 8,0000 150.000
2013-01-30 AFEYAN NOUBAR 125.000 2,0000 31.250 8,0000 250.000
2013-01-30 AFEYAN NOUBAR 250.000 2,0000 62.500 8,0000 500.000

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

BGMD / BG Medicine, Inc. Insider Trades
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse

In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in BGMD / BG Medicine, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Min
Preis bei
Min
Max Verlust
Vermieden($)
Max Verlust
Vermieden(%)
2015-12-09 AFEYAN NOUBAR 2.508 0,5600 2.508 0,5600 1.404 366 0.0474 -1.285 -91,53
2015-12-09 AFEYAN NOUBAR 43.930 0,5600 43.930 0,5600 24.601
2015-07-27 AFEYAN NOUBAR 265 2,2700 265 2,2700 602
2015-07-27 AFEYAN NOUBAR 265 2,2700 265 2,2700 602
2015-07-27 AFEYAN NOUBAR 530 2,2700 530 2,2700 1.203
2015-07-27 AFEYAN NOUBAR 3.390 2,2700 3.390 2,2700 7.695
2015-07-27 AFEYAN NOUBAR 265 2,2700 265 2,2700 602
2015-07-27 AFEYAN NOUBAR 265 2,2700 265 2,2700 602
2015-07-27 AFEYAN NOUBAR 206 2,2700 206 2,2700 468

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

BGMD / BG Medicine, Inc. Insider Trades
Transaktionshistorie

Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.

Datei
Datum
Handel
Datum
Form Insider Ticker Wertpapier-Titel Code 10b5-1 Direkt Ausführung
Preis
Einheit
Preis
Eimheiten
Verändert
Wert
Geändert (1K)
Verbleibende
Optionen
Verbleibende
Aktien
2016-06-27 3 Seawell Haygood Paterson Sr BGMD Common Stock D 2.587.930
2016-06-27 3 Seawell Haygood Paterson Sr Spouse BGMD Common Stock I 1.308.965
2016-06-27 3 Seawell Haygood Paterson Sr Spouse BGMD Common Stock I 1.308.965
2016-06-27 3 Seawell Haygood Paterson Sr BGMD Common Stock D 2.587.930
2016-05-04 2014-04-14 4 Adourian Aram S. BGMD Stock Option (right to buy) M - Exercise D 0,90 -12.000 16.036
2016-05-04 2014-04-14 4 Adourian Aram S. BGMD Common Stock M - Exercise D 0,9000 12.000 11 40.036
2016-04-04 2016-03-31 4 HALL STEPHEN P BGMD Common Stock F - Taxes D 0,3600 -8.986 -3 31.034
2016-04-04 2016-03-31 4 SOHMER PAUL R BGMD Common Stock F - Taxes D 0,3600 -15.493 -6 53.161
2016-04-04 2016-03-31 4 Adourian Aram S. BGMD Common Stock F - Taxes D 0,3600 -7.456 -3 35.770
2016-02-05 2016-02-04 4 LUBER JEFFREY R BGMD Stock option (right to buy) A - Award D 0,29 10.000 10.000
2015-12-11 2015-12-09 4 AFEYAN NOUBAR Held by Atlast LP BGMD Common Stock S - Sale I 0,5600 -2.508 -1 0
2015-12-11 2015-12-09 4 AFEYAN NOUBAR BGMD Common Stock S - Sale D 0,5600 -43.930 -25 0
2015-11-20 2015-11-18 4 PAPADOPOULOS STELIOS BGMD Stock Option (right to buy) A - Award D 0,52 5.000 5.000
2015-11-20 2015-11-18 4 AFEYAN NOUBAR BGMD Stock Option (right to buy) A - Award D 0,52 5.000 5.000
2015-11-20 2015-11-18 4 OCONNOR JAMES F O BGMD Stock Option (right to buy) A - Award D 0,52 12.500 12.500
2015-11-20 2015-11-18 4 WILCOX HARRY W BGMD Stock Option (right to buy) A - Award D 0,52 5.000 5.000
2015-08-19 2015-08-15 4 Adourian Aram S. BGMD Common Stock F - Taxes D 0,8300 -6.233 -5 40.226
2015-08-19 2015-08-15 4 SOHMER PAUL R BGMD Common Stock F - Taxes D 0,8300 -13.321 -11 68.654
2015-08-19 2015-08-15 4 HALL STEPHEN P BGMD Common Stock F - Taxes D 0,8300 -7.505 -6 39.995
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -8.410 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -4.205 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -4.205 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -4.205 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -4.205 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -53.857 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -530 -1 786.970
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock X - Other I 0,1400 8.410 1 787.500
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -265 -1 779.090
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -265 -1 779.090
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -265 -1 779.090
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -265 -1 779.090
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock X - Other I 0,1400 4.205 1 779.355
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock X - Other I 0,1400 4.205 1 779.355
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock X - Other I 0,1400 4.205 1 779.355
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock X - Other I 0,1400 4.205 1 779.355
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -3.390 -8 763.330
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock X - Other I 0,1400 53.857 8 766.720
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -508 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -254 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -254 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -254 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -254 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,14 -3.256 0
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -32 -0 58.232
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock X - Other I 0,1400 508 0 58.264
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -16 -0 57.756
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -16 -0 57.756
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -16 -0 57.756
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -16 -0 57.756
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock X - Other I 0,1400 254 0 57.772
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock X - Other I 0,1400 254 0 57.772
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock X - Other I 0,1400 254 0 57.772
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock X - Other I 0,1400 254 0 57.772
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock S - Sale I 2,2700 -206 -0 56.804
2015-07-29 2015-07-27 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Common Stock X - Other I 0,1400 3.256 0 57.010
2015-07-16 3 Flagship Ventures Fund 2007, L.P. Held by Flagship Ventures Fund 2007, L.P. BGMD Common Stock I 882.142
2015-07-16 3 Flagship Ventures Fund 2007, L.P. Held by Flagship Ventures Fund 2007, L.P. BGMD Common Stock I 882.142
2015-07-16 3 Flagship Ventures Fund 2007, L.P. Held by Flagship Ventures Fund 2007, L.P. BGMD Common Stock I 882.142
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. BGMD Series A Preferred Stock P - Purchase I 1,7003 397.072 675 497.729
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. BGMD Series A Preferred Stock C - Conversion I 100.657 100.657
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Secured Convertible Promissory Note C - Conversion I 1,70
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. BGMD Secured Convertible Promissory Note C - Conversion I 1,70
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Secured Convertible Promissory Note J - Other I 1,70
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. BGMD Secured Convertible Promissory Note J - Other I 1,70
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Series A Preferred Stock P - Purchase I 1,7003 53.465 91 67.018
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Series A Preferred Stock C - Conversion I 13.553 13.553
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Secured Convertible Promissory Note C - Conversion I 1,70
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. BGMD Secured Convertible Promissory Note J - Other I 1,70
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Series A Preferred Stock P - Purchase I 1,7003 725.725 1.234 909.696
2015-07-16 2015-07-14 4 AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. BGMD Series A Preferred Stock C - Conversion I 183.971 183.971
2015-02-24 2015-02-20 4 SOHMER PAUL R BGMD Stock Option (right to buy) A - Award D 0,82 200.000 200.000
2015-02-24 2015-02-20 4 HALL STEPHEN P BGMD Stock Option (right to buy) A - Award D 0,82 140.000 140.000
2015-02-24 2015-02-20 4 Adourian Aram S. BGMD Stock Option (right to buy) A - Award D 0,82 140.000 140.000
2014-12-11 2014-12-11 4 KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. BGMD Common Stock S - Sale I 0,3000 -369.112 -111 0
2014-12-11 2014-12-11 4 KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. BGMD Common Stock S - Sale I 0,3000 -18.468 -6 0
2014-12-11 2014-12-10 4 KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. BGMD Common Stock S - Sale I 0,3200 -109.248 -35 369.112
2014-12-11 2014-12-10 4 KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. BGMD Common Stock S - Sale I 0,3200 -5.472 -2 18.468
2014-12-11 2014-12-09 4 KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. BGMD Common Stock S - Sale I 0,3600 -125.789 -45 478.360
2014-12-11 2014-12-09 4 KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. BGMD Common Stock S - Sale I 0,3600 -6.301 -2 23.940
2014-12-05 2014-12-04 4 AFEYAN NOUBAR BGMD Common Stock J - Other D 11.190 0
2014-12-05 2014-12-04 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock J - Other I -703.655 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -12.183 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -12.183 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -12.183 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -5.988 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,04 -12.021 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock S - Sale I 0,4600 -440 -0 703.655
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock S - Sale I 0,4600 -440 -0 703.655
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock S - Sale I 0,4600 -440 -0 703.655
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock X - Other I 0,0200 12.183 0 704.095
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock X - Other I 0,0200 12.183 0 704.095
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock X - Other I 0,0200 12.183 0 704.095
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock S - Sale I 0,4600 -216 -0 668.426
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock X - Other I 0,0200 5.988 0 668.642
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock S - Sale I 0,4600 -927 -0 662.654
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC BGMD Common Stock X - Other I 0,0400 12.021 0 663.581
2014-12-05 2014-12-04 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock J - Other I -98.352 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -1.724 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -1.724 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -1.724 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -847 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,04 -464 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock S - Sale I 0,4600 -63 -0 98.352
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock S - Sale I 0,4600 -63 -0 98.352
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock S - Sale I 0,4600 -63 -0 98.352
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock X - Other I 0,0200 1.724 0 98.415
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock X - Other I 0,0200 1.724 0 98.415
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock X - Other I 0,0200 1.724 0 98.415
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock S - Sale I 0,4600 -31 -0 93.369
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock X - Other I 0,0200 847 0 93.400
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock S - Sale I 0,4600 -37 -0 92.553
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by ST NewcoGen LLC BGMD Common Stock X - Other I 0,0400 464 0 92.590
2014-12-05 2014-12-04 4 KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. BGMD Common Stock J - Other I 592.959 604.149
2014-12-05 2014-12-04 4 KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. BGMD Common Stock J - Other I 11.190 11.190
2014-12-05 2014-12-04 4 KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. BGMD Common Stock J - Other I 29.648 30.241
2014-12-05 2014-12-04 4 KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. BGMD Common Stock J - Other I 593 593
2014-12-05 2014-12-04 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock J - Other I -98.570 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -1.729 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -1.729 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -1.729 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -850 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,04 -499 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock S - Sale I 0,4600 -63 -0 98.570
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock S - Sale I 0,4600 -63 -0 98.570
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock S - Sale I 0,4600 -63 -0 98.570
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock X - Other I 0,0200 1.729 0 98.633
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock X - Other I 0,0200 1.729 0 98.633
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock X - Other I 0,0200 1.729 0 98.633
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock S - Sale I 0,4600 -32 -0 93.572
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock X - Other I 0,0200 850 0 93.604
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock S - Sale I 0,4600 -39 -0 92.754
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC BGMD Common Stock X - Other I 0,0400 499 0 92.793
2014-12-05 2014-12-04 4 AFEYAN NOUBAR Held by Atlast LP BGMD Common Stock J - Other I 10.029 10.029
2014-12-05 2014-12-04 4 AFEYAN NOUBAR BGMD Common Stock J - Other D 164.528 175.718
2014-12-05 2014-12-04 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Common Stock J - Other I -2.484.192 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -17.080 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -17.080 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -17.080 0
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Common Stock S - Sale I 0,4600 -616 -0 2.484.192
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Common Stock S - Sale I 0,4600 -616 -0 2.484.192
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Common Stock X - Other I 0,0200 17.080 0 2.484.808
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Common Stock X - Other I 0,0200 17.080 0 2.484.808
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Common Stock X - Other I 0,0200 17.080 0 2.484.808
2014-12-05 2014-12-03 4 AFEYAN NOUBAR Held by NewcoGen Group LLC BGMD Common Stock S - Sale I 0,4600 -616 -0 7.298.474
2014-10-17 2014-10-16 4 SOHMER PAUL R BGMD Common Stock A - Award D 327.900 327.900
2014-10-17 2014-10-16 4 HALL STEPHEN P BGMD Common Stock A - Award D 190.200 190.200
2014-10-17 2014-10-16 4 Adourian Aram S. BGMD Common Stock A - Award D 157.800 185.836
2014-06-05 2014-06-03 4 AFEYAN NOUBAR BGMD Stock Option (right to buy) A - Award D 1,00 4.205 4.205
2014-06-05 2014-06-03 4 BAINS HARRISON M JR BGMD Stock Option (right to buy) A - Award D 1,00 4.205 4.205
2014-06-05 2014-06-03 4 PAPADOPOULOS STELIOS BGMD Stock Option (right to buy) A - Award D 1,00 4.205 4.205
2014-06-05 2014-06-03 4 Posner Brian S BGMD Stock Option (right to buy) A - Award D 1,00 4.205 4.205
2014-06-05 2014-06-03 4 Harris Timothy J.R. BGMD Stock Option (right to buy) A - Award D 1,00 4.205 4.205
2014-06-05 2014-06-03 4 Bancel Stephane BGMD Stock Option (right to buy) A - Award D 1,00 4.205 4.205
2014-02-06 2014-02-04 4 SOHMER PAUL R BGMD Stock Option (right to buy) A - Award D 1,15 250.000 250.000
2014-02-06 2014-02-04 4 Adourian Aram S. BGMD Stock Option (right to buy) A - Award D 1,15 93.000 93.000
2014-02-06 2014-02-04 4 Adourian Aram S. BGMD Stock Option (right to buy) A - Award D 1,15 50.000 50.000
2014-02-06 2014-02-04 4 Rader Anastasia BGMD Stock Option (right to buy) A - Award D 1,15 42.000 42.000
2014-02-06 2014-02-04 4 Rader Anastasia BGMD Stock Option (right to buy) A - Award D 1,15 40.000 40.000
2013-12-18 2013-12-17 4 HALL STEPHEN P BGMD Stock Option (right to buy) A - Award D 0,89 150.000 150.000
2013-11-04 2013-11-01 4 Bancel Stephane BGMD Stock Option (right to buy) A - Award D 0,62 101.351 101.351
2013-08-05 2013-08-01 4 Bancel Stephane BGMD Stock Option (right to buy) A - Award D 1,20 52.083 52.083
2013-06-14 2013-06-12 4 Posner Brian S BGMD Stock Option (Right to Buy) A - Award D 1,68 4.205 4.205
2013-06-14 2013-06-12 4 PAPADOPOULOS STELIOS BGMD Stock Option (right to buy) A - Award D 1,68 4.205 4.205
2013-06-14 2013-06-12 4 AFEYAN NOUBAR BGMD Stock Option (right to buy) A - Award D 1,68 4.205 4.205
2013-06-14 2013-06-12 4 BAINS HARRISON M JR BGMD Stock Option (right to buy) A - Award D 1,68 4.205 4.205
2013-06-14 2013-06-12 4 Harris Timothy J.R. BGMD Stock Option (right to buy) A - Award D 1,68 4.205 4.205
2013-05-14 2013-05-10 4 SOHMER PAUL R BGMD Stock Options (right to buy) A - Award D 1,67 700.000 700.000
2013-05-03 2013-05-01 4 Bancel Stephane BGMD Stock Option (right to buy) A - Award D 1,61 39.473 39.473
2013-04-30 2013-04-26 4 Adourian Aram S. BGMD Stock Option (right to buy) A - Award D 1,69 200.000 200.000
2013-04-30 2013-04-26 4 Rader Anastasia BGMD Stock Option (right to buy) A - Award D 1,69 75.000 75.000
2013-02-01 2013-01-30 4 PAPADOPOULOS STELIOS BGMD Common Stock P - Purchase D 2,0000 250.000 500 1.187.713
2013-02-01 2013-01-30 4 AFEYAN NOUBAR By Flagship Ventures Fund 2007, L.P. BGMD Common Stock P - Purchase I 2,0000 1.050.000 2.100 1.764.286
2013-02-01 2013-01-30 4 AFEYAN NOUBAR By Applied Genomic Technology Capital Fund, L.P. BGMD Common Stock P - Purchase I 2,0000 500.000 1.000 2.851.447
2013-02-01 2013-01-30 4 AFEYAN NOUBAR By AGTC Advisors Fund, L.P. BGMD Common Stock P - Purchase I 2,0000 75.000 150 215.013
2013-02-01 2013-01-30 4 AFEYAN NOUBAR By NewcoGen Equity Investors LLC BGMD Common Stock P - Purchase I 2,0000 125.000 250 651.560
2013-02-01 2013-01-30 4 AFEYAN NOUBAR By NewcoGen Group LLC BGMD Common Stock P - Purchase I 2,0000 250.000 500 2.434.800
2012-12-12 2012-12-10 4 Abdalian Charles H Jr BGMD Stock Option (right to buy) A - Award D 1,33 140.000 140.000
2012-11-20 2012-11-19 4 Posner Brian S BGMD Common Stock P - Purchase D 1,1650 10.000 12 20.000
2012-11-19 2012-11-15 4 Bancel Stephane BGMD Common Stock P - Purchase D 1,2600 100.000 126 123.167
2012-10-09 2012-10-04 4 Adourian Aram S. BGMD Stock Option (right to buy) A - Award D 3,61 40.000 40.000
2012-09-17 2012-09-13 4 Bancel Stephane BGMD Common Stock P - Purchase D 3,7000 1.381 5 23.167
2012-08-22 2012-08-21 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Common Stock J - Other I -298.137 0
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -6.422 0
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -6.422 0
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -6.422 0
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,03 -2.353 0
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Common Stock S - Sale I 5,8300 -23 -0 298.137
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Common Stock S - Sale I 5,8300 -23 -0 298.137
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Common Stock X - Other I 0,0200 6.422 0 298.160
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Common Stock X - Other I 0,0200 6.422 0 298.160
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Common Stock S - Sale I 5,8300 -23 -0 285.339
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Common Stock X - Other I 0,0200 6.422 0 285.362
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Common Stock S - Sale I 5,8300 -13 -0 278.940
2012-08-22 2012-08-20 4 AFEYAN NOUBAR By NewcoGen-Elan LLC BGMD Common Stock X - Other I 0,0300 2.353 0 278.953
2012-08-10 2012-08-08 4 Densel William BGMD Stock Option (right to buy) A - Award D 6,90 100.000 100.000
2012-06-13 2012-06-11 4 AFEYAN NOUBAR BGMD Stock Option (right to buy) A - Award D 5,69 4.205 4.205
2012-06-13 2012-06-11 4 BAINS HARRISON M JR BGMD Stock Option (right to buy) A - Award D 5,69 4.205 4.205
2012-06-13 2012-06-11 4 PAPADOPOULOS STELIOS BGMD Stock Option (right to buy) A - Award D 5,69 4.205 4.205
2012-06-13 2012-06-11 4 Harris Timothy J.R. BGMD Stock Option (right to buy) A - Award D 5,69 4.205 4.205
2012-06-11 2012-06-08 4 Muntendam Pieter BGMD Common Stock S - Sale D 5,2900 -3.965 -21 78.483
2012-06-11 2012-06-07 4 Muntendam Pieter BGMD Common Stock S - Sale D 5,5000 -30.021 -165 82.448
2012-06-01 2012-05-30 4 Muntendam Pieter BGMD Stock Option (right to buy) M - Exercise D 0,90 -100.000 82.239
2012-06-01 2012-05-30 4 Muntendam Pieter BGMD Common Stock M - Exercise D 0,9000 100.000 90 112.469
2012-05-24 2012-05-23 4 Bouvier Eric BGMD Common Stock P - Purchase D 3,9500 10.000 40 10.000
2012-05-23 2012-05-23 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock J - Other I -130.867 0
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -7.001 0
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -7.001 0
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -7.001 0
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,02 -2.580 0
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Warrant to Purchase Common Stock (right to buy) X - Other I 0,03 -2.497 0
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock S - Sale I 3,9500 -36 -0 130.867
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock S - Sale I 3,9500 -36 -0 130.867
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock S - Sale I 3,9500 -36 -0 130.867
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock X - Other I 0,0200 7.001 0 130.903
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock X - Other I 0,0200 7.001 0 130.903
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock X - Other I 0,0200 7.001 0 130.903
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock S - Sale I 3,9500 -14 -0 109.972
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock X - Other I 0,0200 2.580 0 109.986
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock S - Sale I 3,9500 -19 -0 107.406
2012-05-23 2012-05-21 4 AFEYAN NOUBAR By NewcoGen-PE LLC BGMD Common Stock X - Other I 0,0300 2.497 0 107.425
2012-05-23 2012-05-22 4 Posner Brian S BGMD Common Stock P - Purchase D 4,0400 10.000 40 10.000
2012-05-21 2012-05-17 4 Bancel Stephane BGMD Common Stock P - Purchase D 3,8400 5.008 19 21.786
2012-04-19 2012-04-17 4 van der Meer Pieter By Gilde Europe Food & Agribusiness Fund B.V. BGMD Common Stock S - Sale I 6,6000 -200.000 -1.320 1.635.432
2012-03-21 2012-03-19 4 Adourian Aram S. BGMD Stock Option (right to buy) M - Exercise D 0,90 -7.009 0
2012-03-21 2012-03-19 4 Adourian Aram S. BGMD Common Stock M - Exercise D 0,9000 7.009 6 28.036
2012-02-29 2012-02-27 4 AFEYAN NOUBAR BGMD Stock Option (right to buy) A - Award D 7,78 4.205 4.205
2012-02-29 2012-02-27 4 BAINS HARRISON M JR BGMD Stock Option (right to buy) A - Award D 7,78 4.205 4.205
2012-02-29 2012-02-27 4 PAPADOPOULOS STELIOS BGMD Stock Option (right to buy) A - Award D 7,78 4.205 4.205
2012-02-29 2012-02-27 4 Harris Timothy J.R. BGMD Stock Option (right to buy) A - Award D 7,78 4.205 4.205
2012-02-29 2012-02-27 4 Bancel Stephane BGMD Stock Option (right to buy) A - Award D 7,78 4.205 4.205
2012-02-24 2012-02-22 4 ROGERS MICHAEL W BGMD Stock Option (right to buy) A - Award D 7,84 35.000 35.000
2012-02-24 2012-02-22 4 GORDON NEAL BGMD Stock Option (right to buy) A - Award D 7,84 30.000 30.000
2012-02-24 2012-02-22 4 Bancel Stephane BGMD Common Stock P - Purchase D 2.778 16.778
2012-02-24 2012-02-22 4 Adourian Aram S. BGMD Stock Option (right to buy) A - Award D 7,84 40.000 40.000
2012-02-24 2012-02-22 4 Rader Anastasia BGMD Stock Option (right to buy) A - Award D 7,84 30.000 30.000
2012-02-24 2012-02-22 4 Miller Stephen R. BGMD Stock Option (right to buy) A - Award D 7,84 30.000 30.000
2012-02-15 2012-02-13 4 Posner Brian S BGMD Stock Option (right to buy) A - Award D 8,27 8.410 8.410
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista